Mirum Pharmaceuticals Inc. MIRM
$102.04
▼ -0.20% 24H
About
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases. Its primary objective is to address unmet medical needs, particularly in the sphere of liver diseases where few treatment options exist. Mirum is especially recognized for its work…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees418
TickerMIRM
Statistics
Market Cap$6.22B
Revenue (TTM)$521.3M
Net Income-$23.4M
Net Margin-4.5%
EPS$-0.47
P/E-215.88
P/S10.66
P/B25.01
EV/EBITDA-113.28
ROE-335.8%
Dividend Yield—
Price$102.04
Data: Twelve Data · Revenue = mcap / P/S